Peace the question was asked re a cr but there is no plan for one in the immediate future. Happy to hear they are expecting to be reinbursed about 1 mill for r and d.
Engaging a high profile company experienced in license negotiations with big pharma is absolutely fantastic news and will gain IMO the highest bid for 1103. Bob Moses also reiterated the level of interest they have had and how up against peers in our industry we are extremely undervalued.
Great meeting all in all and could definitely hear Marks enthusiasm regarding the approaching results!
Ann: AGM Presentation , page-10
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.002(2.47%) |
Mkt cap ! $81.90M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.1¢ | 7.8¢ | $1.034M | 12.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 349999 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 305419 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |